Dublin, Sept. 28, 2020 (GLOBE NEWSWIRE) -- The "Global Mice Model Market by Mice Type (Inbred, Knockout), Technology (CRISPR, TALEN, ZFN), Application (Oncology, Diabetes, Immunology), Service (Breeding, Cryopreservation, Genetic Testing), Care Products (Cages, Bedding, Feed), and Region - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global mice model market size is projected to reach USD 1.9 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.4% during the forecast period.

The major factors driving the growth of this market are the Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing implications of mouse clinical trials (MCTs) for more predictive outcomes and ongoing innovations in mice models are driving the growth of the global mice model industry. However, Implementation of laws and regulations for animal protection and welfare has enforced restrictive practices and bans on the use of animals for different purposes that may restrict the growth of this market to a certain extent.

Asia Pacific: The fastest-growing region in the mice model market

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Several global pharmaceutical firms have entered the APAC market to tap the significant growth opportunities in emerging Asian countries and lower their production costs by shifting their drug discovery R&D operations and manufacturing to the region. A large number of qualified researchers and low-cost operations in APAC countries, such as India and China, are some of the major factors supporting this trend.

North America: The largest share of the drug discovery services market

North America, which includes the US and Canada, accounted for the largest share of the mice model market. The large share of the North America region can be attributed to the presence of major players operating in the mice model market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights4.1 Mice Model Market Overview4.2 Asia-Pacific: Mice Model Market Share, by Mice Care Product and by Country (2019)4.3 Mice Model Market, by Mice Type4.4 Mice Model Market Share, by Service, 2020 Vs. 20254.5 Mice Model Market, by Application, 2020 Vs. 2025 (USD Million)

5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Market Drivers5.2.1.1 Growing Usage of Mice Models in Virology and Infectious Diseases5.2.1.2 Increasing Implications of Mouse Clinical Trials (MCTS) for More Predictive Outcomes5.2.1.3 Increasing Demand for Personalized Medicine5.2.2 Restraints5.2.2.1 Regulations and Laws for the Ethical Use of Animals in Research5.2.3 Opportunities5.2.3.1 CRISPR Emerging as a Powerful Tool in Biomedical Research5.2.3.2 Rising Demand for Humanized Mice Models5.2.4 Challenges5.2.4.1 Development of Alternative Animal Testing Methods5.2.5 Threats5.2.5.1 Growing Use of Rat Models5.3 Impact of the COVID-19 Outbreak on the Growth of the Mice Model Market

6 Regulatory Assessment6.1 Introduction6.2 North America6.3 Europe6.4 China6.5 Japan6.6 India6.7 Australia6.8 Brazil

7 Clinical Studies Assessment7.1 Introduction7.2 Clinical Studies

8 Mice Model Market, by Mice Type8.1 Introduction8.2 Inbred Mice8.2.1 Increasing Applications of Inbred Mice Likely to Drive the Market8.3 Outbred Mice8.3.1 Genetic Diversity Offered by Outbred Mice to Boost the Market8.4 Genetically Engineered Mice8.4.1 Increasing Focus on Personalized Medicines to Drive Demand8.5 Hybrid/Congenic Mice8.5.1 Increasing Use of Congenic Mice in Biomedical Research Contributes to Market Growth8.6 Conditioned/Surgically Modified Mice8.6.1 Increasing Incidence of Metabolic Diseases to Drive the Market8.7 Spontaneous Mutant Mice8.7.1 Advancements in Biomedical Research and Increasing Applications to Boost Demand

9 Mice Model Market, by Service9.1 Introduction9.2 Breeding9.2.1 Growing Number of Mice Model Studies to Boost the Market9.3 Cryopreservation9.3.1 Need for Preservation of Novel Mice Models Likely to Drive the Market9.4 Quarantine9.4.1 Rising Demand for Germ-Free Mice to Boost Market9.5 Rederivation9.5.1 Stringent Quality Assurance Standards to Boost the Market9.6 Model In-Licensing9.6.1 Increasing Independent Research by Scientific Community Likely to Fuel Market Growth9.7 Genetic Testing9.7.1 Rising Demand for Transgenic Mice Likely to Drive the Market9.8 Other Services

10 Mice Model Market, by Technology10.1 Introduction10.2 CRISPR/Cas910.2.1 Advantages of CRISPR Likely to Boost Segment Growth10.3 Microinjection10.3.1 High Success Rate and Lack of Constraints to Propel Segment10.4 Embryonic Stem Cell Injection10.4.1 Growing Demand for Targeted Mice Models to Propel the Market10.5 Nuclear Transfer10.5.1 Potential to Produce Identical Mice is Likely to Drive Market Growth10.6 Other Technologies10.6.1 Sperm-Mediated Gene Transfer10.6.2 Virus/Vector-Mediated Gene Transfer10.6.3 Liposome-Mediated Dna and Electroporation of DNA10.6.4 Biolistics10.6.5 Talens and ZFNS

11 Mice Model Market, by Application11.1 Introduction11.2 Oncology Studies11.2.1 Increasing Implications of Mice Models in Study of Cancer to Drive the Market11.3 Immunology and Inflammation Studies11.3.1 Development of Advanced Models for Human Immunology Studies to Boost Market Growth11.4 Endocrine Metabolic Studies11.4.1 Growing Prevalence of Metabolic Disorders Likely to Drive the Market11.4.2 Diabetes Studies11.4.3 Other Endocrine Metabolic Studies11.5 Cardiovascular Studies11.5.1 Rising Burden of Cardiovascular Disorders Has Boosted Overall R&D Activity11.6 Central Nervous System (CNS) Studies11.6.1 Increasing Focus on Mice Model Development for CNS Disorders to Propel Market11.7 Genetic Studies11.7.1 Advancements in Gene Editing Techniques to Drive the Market11.8 Infectious Disease Studies11.8.1 Increasing Outbreaks of Infectious Diseases to Propel Drug Development Activities11.9 Other Disease Studies

12 Mice Model Market, by Mice Care Product12.1 Introduction12.2 Cages12.2.1 Development of Different Cage Systems to Drive the Market12.3 Feed12.3.1 Preference for Healthy and Powered Diet to Drive the Market12.4 Bedding12.4.1 Environmental Enrichment Strategy for Welfare of Laboratory Animals Likely to Boost Market Growth12.5 Other Mice Care Products

13 Mice Model Market, by Region

14 Competitive Landscape14.1 Introduction14.2 Market Ranking AnalysisFigure 23 Company Ranking in the Mice Model Market, 2019

15 Company Evaluation Matrix and Company Profiles15.1 Overview15.2 Mice Model Market: Company Evaluation Matrix15.2.1 Stars15.2.2 Emerging Leaders15.2.3 Pervasive Companies15.2.4 Participants15.3 Market Evaluation Framework15.4 Competitive Scenario15.4.1 Key Product Launches15.4.2 Key Acquisitions15.4.3 Key Collaborations15.4.4 Key Service Expansions15.5 Company Profiles15.5.1 Charles River Laboratories International15.5.2 The Jackson Laboratory15.5.3 Envigo15.5.4 Genoway15.5.5 Taconic Biosciences, Inc.15.5.6 Janvier Labs15.5.7 Harbour Biomed15.5.8 Trans Genic, Inc.15.5.9 Ingenious Targeting Laboratory15.5.10 Polygene15.5.11 GVK Bio15.5.12 Cyagen Biosciences15.5.13 Crown Bioscience Inc. (Subsidiary of JSR Corporation)15.5.14 Transcure Bioservices15.5.15 Ozgene Pty. Ltd.15.5.16 The Andersons, Inc.15.5.17 Fengshi Group15.5.18 Allentown, LLC15.5.19 Innovive15.5.20 Lab Products, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/2smp0w

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Read more from the original source:
Global Mice Model Market Research Report 2020: Increasing Implications of Mouse Clinical Trials (MCTs) for More Predictive Outcomes and Ongoing...